Discussion
Loading...

Post

  • About
  • Code of conduct
  • Privacy
  • Users
  • Instances
  • About Bonfire
datum (n=1)
@datum@zeroes.ca  ·  activity timestamp 4 weeks ago

So I'm reading https://www.medrxiv.org/content/10.1101/2025.08.08.25333305v1.full-text with interest as it ostensibly found metformin didn't meaningfully decrease Long COVID rates

and

participants didn't receive the metformin until a median five days after symptom onset

they cite other work that found a ~40% reduction in LC with metformin dose:

In the COVID-OUT randomized trial, the HR for participant-reported clinician diagnosis of LC in those randomized to 14 days of metformin was 0.59 (95% CI 0.39 to 0.89)

and I am left wondering if maybe "metformin should be taken as early as possible during acute COVID-19" is what the new study really suggests

#SARSCoV2#COVID#COVID19 #LongCOVID #metformin #CovidIsNotOver

  • Copy link
  • Flag this post
  • Block
datum (n=1)
@datum@zeroes.ca replied  ·  activity timestamp 4 weeks ago

Someone (you know who you are) pointed this https://www.sciencedirect.com/science/article/pii/S2589004224018959 out

which hints that maybe metformin's mechanism of action against LC might be to make it harder for C19 to establish viral reservoirs

haven't read the paper in depth but a very interesting notion

if true then we could expect to see meformin

  • reducing LC symptom clusters downstream from persistence, but
  • reducing less LC from symptoms downstream from immune dysregulation, direct epithelial and BBB damage, and direct organ damage

#COVID#SARSCoV2#COVID19 #LongCOVID #CovidIsNotOver

  • Copy link
  • Flag this comment
  • Block
Log in

bonfire.cafe

A space for Bonfire maintainers and contributors to communicate

bonfire.cafe: About · Code of conduct · Privacy · Users · Instances
Bonfire social · 1.0.0-rc.2.21 no JS en
Automatic federation enabled
  • Explore
  • About
  • Members
  • Code of Conduct
Home
Login